These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Chemotherapy of melanoma of the extremities by perfusion: fourteen years clinical experience. Krementz ET; Ryan RF Ann Surg; 1972 Jun; 175(6):900-17. PubMed ID: 4625027 [No Abstract] [Full Text] [Related]
8. Long-term outcome of hyperthermic isolated limb perfusion (HILP) in the treatment of locoregionally metastasised malignant melanoma of the extremities. Boesch CE; Meyer T; Waschke L; Merkel S; Goehl J; Hohenberger W; Knorr C Int J Hyperthermia; 2010 Feb; 26(1):16-20. PubMed ID: 20100048 [TBL] [Abstract][Full Text] [Related]
9. A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US. Beasley GM; Caudle A; Petersen RP; McMahon NS; Padussis J; Mosca PJ; Zager JS; Hochwald SN; Grobmyer SR; Delman KA; Andtbacka RH; Noyes RD; Kane JM; Seigler H; Pruitt SK; Ross MI; Tyler DS J Am Coll Surg; 2009 May; 208(5):706-15; discussion 715-7. PubMed ID: 19476821 [TBL] [Abstract][Full Text] [Related]
10. Regional isolated limb perfusion of melanoma intransit metastases using mechlorethamine (nitrogen mustard). Shiu MH; Knapper WH; Fortner JG; Yeh S; Horowitz G; Schnog J; Guerra J; Gould-Rossbach P; Ray C J Clin Oncol; 1986 Dec; 4(12):1819-26. PubMed ID: 3783205 [TBL] [Abstract][Full Text] [Related]
11. Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion. Beasley GM; Petersen RP; Yoo J; McMahon N; Aloia T; Petros W; Sanders G; Cheng TY; Pruitt SK; Seigler H; Tyler DS Ann Surg Oncol; 2008 Aug; 15(8):2195-205. PubMed ID: 18528730 [TBL] [Abstract][Full Text] [Related]
12. Isolation perfusion for malignant melanoma of the extremity: a review. Cumberlin R; De Moss E; Lassus M; Friedman M J Clin Oncol; 1985 Jul; 3(7):1022-31. PubMed ID: 2410572 [TBL] [Abstract][Full Text] [Related]
13. Palliation of regional symptoms of advanced extremity melanoma by isolated limb perfusion with melphalan and high-dose tumor necrosis factor. Fraker DL; Alexander HR; Andrich M; Rosenberg SA Cancer J Sci Am; 1995; 1(2):122-30. PubMed ID: 9166465 [TBL] [Abstract][Full Text] [Related]
14. Hyperthermic isolated limb perfusion increases circulating levels of inflammatory cytokines. Quinn TD; Polk HC; Edwards MJ Cancer Immunol Immunother; 1995 Apr; 40(4):272-75. PubMed ID: 7750126 [TBL] [Abstract][Full Text] [Related]
15. Isolated limb perfusion: a literature review. Schaadt J; Crowley R; Miller D; Kavanah M J Extra Corpor Technol; 2002 Jun; 34(2):130-43. PubMed ID: 12139123 [TBL] [Abstract][Full Text] [Related]
16. Perfusion of melanoma. 105 isolated perfusions in 92 patients. Golomb FM Oncology; 1972; 26(2):197-205. PubMed ID: 4626136 [No Abstract] [Full Text] [Related]
17. Long-term results of hyperthermic, isolated limb perfusion for melanoma: a reflection of tumor biology. Sanki A; Kam PC; Thompson JF Ann Surg; 2007 Apr; 245(4):591-6. PubMed ID: 17414608 [TBL] [Abstract][Full Text] [Related]
18. Current techniques of hyperthermic isolated limb perfusion for malignant melanoma. Tominaga R; Kohno H; Mayumi H; Shiraishi K; Nagae S; Nakayama J; Yasui H Surg Today; 2000; 30(4):339-42. PubMed ID: 10795866 [TBL] [Abstract][Full Text] [Related]
19. Circuit and protocol for hypoxic hyperthermic isolated limb perfusion to treat malignant melanoma. Innet LM; Haripershad V; Van Den Berg J; Cooper L Perfusion; 2001 Jul; 16(4):325-30. PubMed ID: 11486853 [TBL] [Abstract][Full Text] [Related]